A large majority of high-grade lesions in the female genital ... the vaccine was 100% effective in preventing cervical intraepithelial neoplasia (CIN)1-3 and adenocarcinoma in situ (AIS ...

An investigational therapeutic vaccine showed clinical effectiveness in patients with human papillomavirus (HPV)16-positive ...

High-risk HPV DNA is detected in more than 99% of cervical carcinoma worldwide. HPV genotyping is essential for evaluating the risk of the development of high-grade cervical neoplasia. HPV DNA ...

rates of cervical intraepithelial neoplasia (CIN) grades 2-3 and adenocarcinoma in situ (AIS), defined as CIN2+, decreased by 79%, and rates of CIN grade 3 and AIS, defined as CIN3+, decreased by ...

The Papanicolaou (Pap) smear is commonly used to screen for cervical cancer and ... Administration to screen for high-grade cervical intraepithelial neoplasia. Women with positive test results ...